Clinical Progression and Costs in Benign Prostatic Hyperplasia Patients Treated With Early Versus Delayed Combination Therapy

NCT01435954 · clinicaltrials.gov ↗

COMPLETED

Status

13551

Enrollment

INDUSTRY

Sponsor class

Conditions

Benign Prostatic Hyperplasia

Interventions

DRUG: Early combination therapy
DRUG: Delayed combination therapy

Sponsor

GlaxoSmithKline